Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
about
Prophylactic vaccinations in chronic kidney disease: Current statusA molecular mucosal adjuvant to enhance immunity against pneumococcal infection in the elderlyPertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.Fc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cellsIn vivo mechanisms involved in enhanced protection utilizing an Fc receptor-targeted mucosal vaccine platform in a bacterial vaccine and challenge model.Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infectionTularemia vaccine development: paralysis or progress?Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein AVaccination issues in patients with chronic kidney disease.Towards Identifying Protective B-Cell Epitopes: The PspA Story.Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against S. pneumoniae infection in mice.Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine.Production of the growth factors GM-CSF, G-CSF, and VEGF by human peripheral blood cells induced with metal complexes of human serum γ -globulin formed with copper or zinc ions.Multiple mechanisms mediate enhanced immunity generated by mAb-inactivated F. tularensis immunogen.FcγR mediates TLR2- and Syk-dependent NLRP3 inflammasome activation by inactivated Francisella tularensis LVS immune complexes.Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
P2860
Q26827388-AE3A9A1F-8A2B-4B68-ADDA-20DADE160430Q28084760-8CCBFB30-E35C-47DF-BCF6-4E44094CBF66Q33899407-8B863B62-3201-4513-BCD0-F76D484A4FFBQ34087802-2D0247A4-2164-4865-BB70-490ED80FBBCFQ34890142-4677B4F7-784C-4F98-8802-A1725DB2B6B1Q35563406-EE1B1FDE-579A-4898-8681-A20E22E405F6Q36191618-3F8BD25E-9970-417E-A6A3-CE538D4FC0B6Q36466829-4DD86083-8FDB-4990-905D-2666F5885341Q36908692-282298A9-AC7A-4661-BF41-F00A7863A83EQ37252358-63AA50EC-2726-42DD-B434-F8B7720613BAQ38176987-DB672249-3D7A-4E2B-AE25-E096B39D56DDQ38781789-7229A7C2-0064-4199-81D4-2219BF764311Q40277871-7ABDF7B4-BC86-47B9-8862-119F1D08A62AQ40379071-B7D220CD-8FE4-4AD7-B38A-68618E188B89Q41872476-021D5D8C-873B-4730-823D-6D0990EC37A0Q42096393-B7F6069D-C7B2-42C4-9332-E61CF11B37F8Q45832383-7CA9FD6D-6C6B-4E48-90C6-51AB6BE420FCQ47359574-0C55DB90-76C9-43DB-AD6E-AE3570FE0BDE
P2860
Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mucosal immunization with an u ...... ediated bactericidal activity.
@ast
Mucosal immunization with an u ...... ediated bactericidal activity.
@en
type
label
Mucosal immunization with an u ...... ediated bactericidal activity.
@ast
Mucosal immunization with an u ...... ediated bactericidal activity.
@en
prefLabel
Mucosal immunization with an u ...... ediated bactericidal activity.
@ast
Mucosal immunization with an u ...... ediated bactericidal activity.
@en
P2093
P2860
P356
P1476
Mucosal immunization with an u ...... ediated bactericidal activity.
@en
P2093
Bibiana V Iglesias
Clifford M Snapper
Constantine Bitsaktsis
Diane R Gosselin
Edmund J Gosselin
Giang Pham
Jesus Colino
Susan K Hollingshead
P2860
P304
P356
10.1128/IAI.05511-11
P407
P577
2011-12-12T00:00:00Z